Bayes Enterprises offers 10 and 1 newly issued share for each share of Finsbury Plc. There...

Transcribed Image Text:

Bayes Enterprises offers £10 and 1 newly issued share for each share of Finsbury Plc. There are 1 million shares in Bayes and 600,000 shares in Finsbury, with market valuations of £120m and £30m, respectively. A) Assuming no synergies and that the current market valuations are a good estimate of both companies' standalone values, what is the value of the offer for a shareholder of Finsbury? B) In some countries large corporate decisions must be approved by firms' shareholders. Should Bayes' shareholders support the deal under its current conditions? What would be Bayes' price after the acquisition? C) D) What level of synergies, in millions of £, would make this offer attractive for both groups of shareholders? How would your answers to (A) and (B) change if the true values of Bayes and Finsbury were £80m and £70m, respectively? Assume that there are no synergies. Bayes Enterprises offers £10 and 1 newly issued share for each share of Finsbury Plc. There are 1 million shares in Bayes and 600,000 shares in Finsbury, with market valuations of £120m and £30m, respectively. A) Assuming no synergies and that the current market valuations are a good estimate of both companies' standalone values, what is the value of the offer for a shareholder of Finsbury? B) In some countries large corporate decisions must be approved by firms' shareholders. Should Bayes' shareholders support the deal under its current conditions? What would be Bayes' price after the acquisition? C) D) What level of synergies, in millions of £, would make this offer attractive for both groups of shareholders? How would your answers to (A) and (B) change if the true values of Bayes and Finsbury were £80m and £70m, respectively? Assume that there are no synergies. Bayes Enterprises offers £10 and 1 newly issued share for each share of Finsbury Plc. There are 1 million shares in Bayes and 600,000 shares in Finsbury, with market valuations of £120m and £30m, respectively. A) Assuming no synergies and that the current market valuations are a good estimate of both companies' standalone values, what is the value of the offer for a shareholder of Finsbury? B) In some countries large corporate decisions must be approved by firms' shareholders. Should Bayes' shareholders support the deal under its current conditions? What would be Bayes' price after the acquisition? C) D) What level of synergies, in millions of £, would make this offer attractive for both groups of shareholders? How would your answers to (A) and (B) change if the true values of Bayes and Finsbury were £80m and £70m, respectively? Assume that there are no synergies. Bayes Enterprises offers £10 and 1 newly issued share for each share of Finsbury Plc. There are 1 million shares in Bayes and 600,000 shares in Finsbury, with market valuations of £120m and £30m, respectively. A) Assuming no synergies and that the current market valuations are a good estimate of both companies' standalone values, what is the value of the offer for a shareholder of Finsbury? B) In some countries large corporate decisions must be approved by firms' shareholders. Should Bayes' shareholders support the deal under its current conditions? What would be Bayes' price after the acquisition? C) D) What level of synergies, in millions of £, would make this offer attractive for both groups of shareholders? How would your answers to (A) and (B) change if the true values of Bayes and Finsbury were £80m and £70m, respectively? Assume that there are no synergies.

Answer rating: 100% (QA)

A Based on the information provided Bayes has 1 million shares valued at 120m so each share is worth ... View the full answer